Photo from Paolo Tarantino/Twitter
Aug 6, 2023, 17:11
Here’s a personal, non-exhaustive selection of highly awaited phase 3 trials that may shape practice within the next year – Paolo Tarantino
With ESMO23 and SABCS23 approaching, we may soon see the results from several potentially practice-changing trials in breast oncology. Here’s a personal, non-exhaustive selection of highly awaited phase 3 trials that may shape practice within the next year.
Source: Paolo Tarantino / Twitter